How to Buy Viatris Stock
Viatris Inc
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets.
Viatris stock last closed at $9.64, down 0.52% from the previous day, and has increased 7.83% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.21 percentage points. Viatris stock is currently +14.49% from its 52-week low of $8.42, and -22.25% from its 52-week high of $12.40.
At the moment, there are 1.2B VTRS shares outstanding. The market cap of VTRS is $11.56B. In the last 24 hours, 5.97M VTRS shares were traded.
How to Buy Viatris Stock
Wondering how to invest in Viatris stock? Here's how.
- Decide where to buy Viatris stock: You need to pick an online brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you figure out where to buy Viatris stock.
- Open a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your investment account: Choose your method of payment and add your information.
- Analyze Viatris stock: The Viatris ticker symbol is VTRS. Is Viatris stock a good investment? Should you buy shares of VTRS? How do VTRS's underlying business fundamentals look? Do top analysts think Viatris is a good buy? Why has VTRS's stock price moved recently? (Hint: Our stock analysis website can help you understand if VTRS is a good stock to buy).
- Execute your VTRS buy order: Decide if you will purchase VTRS shares at the current market price or use a limit order to buy VTRS shares at a given price.
- Monitor your VTRS position: Create a watchlist to key updates about your position in Viatris shares.
Step 1: Decide where to buy Viatris stock
You will need an online brokerage account in order to access the NASDAQ market and buy VTRS stock.
Our preferred brokerage: eToro
Based on our research, eToro is the best place to buy stocks. Here's why:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to global markets: From Tech to Industrials, New York to Tokyo — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro has a community with more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by signing up for an account with eToro now.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the best brokerage, you need to fill out some personal details so you can buy VTRS today.
How to Set Up a New Account on eToro
- Click here to get started.
- Input your personal details to open your new trading account.
- Send your application by clicking the "Create Account" button.
Step 3: Deposit funds into your investment account
Now that you've opened your account on apps for stock market, you can securely and quickly fund your account:
Check out this video walkthrough if you need help depositing money into your brokerage account.
Step 4: Analyze Viatris stock
Once you have identified the best place to buy Viatris stock, it's critical to evaluate their stock before you buy, so you truly wrap your head around the risk and opportunity.
Viatris shares quick numbers
VTRS Zen Score
WallStreetZen was built to help average investors perform better fundamental analysis quickly.
You can view all of the due diligence checks on VTRS's stock page.
Is VTRS stock undervalued?
You can use a variety of different financial metrics, analyses, models, and charts to gauge VTRS's intrinsic value.
Using relative valuations measures:
- VTRS could be undervalued based on its P/E ratio of 6.3x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 26.36x
- VTRS could be undervalued based on its P/B ratio of 0.55x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2x
- VTRS may be undervalued based on its PEG ratio of 0.21x
You can access more valuation research on VTRS's stock here.
VTRS Financials at a glance
Positive Health Checks:
- VTRS profit margin has gone up from 4.4% to 11.9% in the past year.
- Total VTRS debt is lower than 5 years ago, relative to shareholder equity.
- VTRS earnings of $3.14B is not enough to cover its interest payments.
- There are more short-term assets than short-term liabilities on the VTRS balance sheet.
Negative Health Checks:
- There are more long-term liabilities than short-term assets on the VTRS balance sheet.
- VTRS's operating cash flow of $2.50B allows it to safely service it's debt of $18.60B.
- VTRS has a relatively high debt to equity ratio of 1.34.
Is it a good time to buy VTRS stock, according to analysts?
Out of 1 Equities analysts who give forecasts on VTRS, the consensus analyst rating on Viatris is a Strong Sell
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
Latest VTRS Analyst Forecasts
Balaji Prasad, a bottom 14% analyst from Barclays downgrades VTRS to a strong sell rating and announces their VTRS price target of $11.00, on Jun 23, 2023.
You can dig deeper into what analysts are projecting on the Viatris stock forecast page.
VTRS Technicals
VTRS Earnings
Last year, VTRS earnings were $1.85B. Over the past 5 year, VTRS's earnings have gone up by 11.95% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 12.21%.
Last year, VTRS revenue was $15.60B. In the past five year, VTRS's revenue has grown by 5.89% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 24.89%.
Learn more about VTRS's earnings and revenue performance here.
Latest Insiders Trades at VTRS
Over the last 12 months, insiders at VTRS have sold more shares than they have bought.
Xiangyang Sean Ni, President Greater China of VTRS, was the latest VTRS insider to sell. They sold $34,892.43 worth of VTRS stock on Mar 6, 2023.
Get more info about who owns VTRS shares here.
Can I get consistent income from VTRS stock?
Viatris pays a dividend of 2.49%, compared to the Drug Manufacturers - Specialty & Generic industry's average dividend yield of 3.12%. If you owned $1,000 of VTRS stock, you would have been paid $24.90 in the past year.
Viatris dividend payments have consistently grown over the past decade and have remained stable.
Find more analysis about Viatris dividend yield and history here.
VTRS Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Execute your VTRS buy order
You have two primary order types:
- Market order: A market order is an order to buy or sell a stock at the best possible price.
Market orders are mostly the best for newer investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open button and your broker will place your order.
If you need more help investing in stocks on eToro, click the how to video below:
Step 6: Monitor your VTRS position
Now that you own some shares in VTRS, you'll want to keep up with your new investment.
Make a watchlist to track your VTRS stock.
VTRS Feed
How to Buy Stock in Viatris
To reiterate, here are the 6 steps you need to take to buy Viatris stock right now:
- Decide where to buy Viatris stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Viatris stock
- Execute your VTRS buy order
- Monitor your VTRS position
If you need a brokerage account, eToro is our favorite option.
Get Started with eToro TodayIf you want to keep an eye on your investment in Viatris, add VTRS to your watchlist below.
Related Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.